Tyra Biosciences, Inc. (TYRA)
NASDAQ: TYRA · Real-Time Price · USD
29.99
-1.41 (-4.49%)
At close: Feb 11, 2026, 4:00 PM EST
29.66
-0.33 (-1.10%)
After-hours: Feb 11, 2026, 7:45 PM EST
Tyra Biosciences Market Cap
Tyra Biosciences has a market cap or net worth of $1.6 billion as of February 11, 2026. Its market cap has increased by 97.78% in one year.
Market Cap
1.60B
Enterprise Value
1.33B
1-Year Change
97.78%
Ranking
Category
Stock Price
$29.99
Market Cap Chart
Since the IPO on September 15, 2021, Tyra Biosciences's market cap has increased from $654.64M to $1.60B, an increase of 144.59%. That is a compound annual growth rate of 22.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 1.60B | 14.11% |
| Dec 31, 2025 | 1.40B | 91.90% |
| Dec 31, 2024 | 731.18M | 22.61% |
| Dec 29, 2023 | 596.34M | 87.61% |
| Dec 30, 2022 | 317.87M | -44.42% |
| Dec 31, 2021 | 571.90M | -12.64% |
| Sep 15, 2021 | 654.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Definium Therapeutics | 1.70B |
| Enliven Therapeutics | 1.70B |
| Zymeworks | 1.69B |
| Biohaven | 1.68B |
| Immunocore Holdings | 1.67B |
| Oculis Holding AG | 1.67B |
| Celldex Therapeutics | 1.65B |
| uniQure | 1.62B |